BioProcessors
Developing a technology, or platform, that is intended to speed up the drug-development process.
Launch date
Employees
Market cap
-
Enterprise valuation
$40—60m (Dealroom.co estimates Aug 2007.)
Woburn Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$6.0m | Series A | ||
$13.0m | Series B | ||
| N/A | $6.5m | Series B | |
| N/A | $18.0m | Series C | |
$10.0m | Series C | ||
N/A | Acquisition | ||
| Total Funding | $53.5m | ||
Related Content
Recent News about BioProcessors
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.